Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Pre-hypertension

In brief

This study will examine the individual and combined effects of Coreg CR and lisinopril, on cardiovascular health as measured by Rasmussen Disease Score (RDS) in a blinded, placebo controlled comparison over a 9-month study period. Patients to be randomized will have pre-hypertensive blood pressures that do not require anti-hypertensive therapy and at least one additional cardiovascular risk factor.

Key facts

Study ID
NCT00553969
Run by
University of Minnesota
People needed
101
Starts
2007-11-01
Expected to finish
2010-12-01
Last updated by the study team
2018-04-24

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.